A program for PTSD and substance use should explain how it will assess and treat both concerns, including the relationship between symptoms, substance use, and current safety. Having a substance use disorder should not automatically prevent access to evidence-based PTSD treatment. At the same time, medical withdrawal needs and the suitability of a particular setting require individual assessment.
For international care, compare the entire pathway: assessment before travel, the actual clinical program, any separate stabilization service, and treatment after return. A broad dual-diagnosis label is only a starting point. The provider needs to demonstrate how the professionals and interventions work together for the person being admitted.
Assess the relationship without assuming one explanation
The National Institute of Mental Health describes several pathways linking substance use and mental disorders, including shared contributing factors and effects in both directions. A patient’s history should therefore not be reduced automatically to a single claim that all substance use is self-medication or all trauma symptoms are caused by substances.
Ask the team to consider the timeline of traumatic experiences, PTSD symptoms, substance use, sleep, treatment, and periods of relative stability. The purpose is a working formulation that can guide care and be revised. It is not a demand that the patient produce a perfectly complete account before receiving help.
Describe what currently makes daily life difficult and what the person wants to change. PTSD-related avoidance, distressing memories, substance-related problems, and physical health concerns may interact in different ways. The assessment should identify which issues require immediate attention and which can be addressed through a planned course of treatment.
Do not treat the second diagnosis as an automatic barrier
The US National Center for PTSD states that people with PTSD and substance use disorders can benefit from evidence-based trauma-focused treatment. Its discussion of VA/DoD guidance recommends making treatment for both disorders available and not using one disorder as a reason to exclude treatment for the other.
This does not mean every intervention should begin immediately in every clinical situation. Ask the team to explain the person’s readiness, current medical needs, and appropriate sequence. A justified stabilization step is different from a blanket policy that leaves PTSD untreated indefinitely because substance use is also present.
Our integrated care comparison helps examine the coordination. If a service proposes separate phases, ask who is responsible for both concerns during each phase and what criteria guide the next step. The patient should not be left between programs with no one overseeing the combined plan.
Verify the actual PTSD intervention
The VA psychotherapy overview identifies prolonged exposure, cognitive processing therapy, and EMDR among the trauma-focused approaches strongly supported in the 2023 guideline. Ask which method is proposed, who delivers it, and how the choice follows the assessment and the patient’s preferences.
A service may also provide education, coping skills, supportive groups, or relaxation. Those components should be described accurately. Their presence does not establish that the program delivers a structured trauma-focused treatment, and a list of methods should not imply that all have the same evidence for the same purpose.
Our PTSD program guide examines clinical scope and specialist expertise. In the combined presentation, also ask how the therapist communicates with the substance use team and how changes in either concern affect the treatment plan.
Compare concurrent and integrated delivery
The VA co-occurring-disorders overview describes evidence for trauma-focused treatment delivered alongside substance use care and for approaches that combine both within one intervention. It gives COPE, which brings prolonged exposure together with relapse prevention work, as an example. These are ways of organizing clinical care, not proof that a particular private facility delivers them competently.
Ask the provider whether it offers one combined intervention, coordinated sessions with different specialists, or a sequence of services. Any arrangement should have a clear clinical rationale and responsibility for the whole plan. Several clinicians can work coherently if communication is practical and agreed.
| Delivery model | Question that tests coordination |
|---|---|
| One integrated intervention | Who is trained to deliver both components and review the combined goals? |
| Concurrent specialist treatments | How do therapists and prescribers share the formulation and resolve conflicting advice? |
| Planned phases of care | Who manages both concerns now and what determines the transition? |
| Separate external services | Who accepts overall coordination and ensures a direct handover? |
Resolve withdrawal and medical capability before travel
NIAAA warns that alcohol withdrawal can be life-threatening after prolonged heavy drinking and may require medical treatment. Other substances and prescribed medicines can also create specific clinical needs. Give the assessing clinicians the full pattern of use and treatment history.
Ask whether the proposed service provides appropriate withdrawal care, arranges it through a medical partner, or requires stabilization before admission. Confirm the responsible clinician and transfer process. The journey should not become a period in which the patient is expected to manage withdrawal alone.
The multiple-substance withdrawal guide explains the service questions to resolve. A program should be clear about its medical limits without abandoning the psychiatric plan. If a higher level of care is needed first, ask how the PTSD assessment and treatment history will follow the person.
Review treatment for substance use beyond symptom relief
NIMH describes behavioral treatment, medication for certain substance use disorders, and care management as components of integrated care. Ask how the program addresses the actual substance-related pattern and prepares for life outside the residence. Temporary separation from substances is not a complete explanation of the treatment.
Discuss what substance use has been doing in the person’s life and which situations are likely to recur. The clinical work should address the individual’s needs without assuming every episode has the same trigger. A useful plan connects those findings with PTSD treatment and practical recovery goals.
Ask how the team responds to increased urges or a return to use. The response should include appropriate assessment, review, and a plan for continued care. A punitive rule that ends contact without considering the combined needs can leave both parts of the clinical problem unresolved.
Keep prescribing connected with both conditions
Provide the complete medication list, including medicines used for sleep, anxiety, pain, or other conditions. Ask what each treatment is intended to address and who reviews interactions, benefits, and adverse effects. A prescription for PTSD symptoms does not automatically constitute treatment for a substance use disorder.
The VA overview distinguishes short-term medical use of benzodiazepines in alcohol withdrawal from ongoing treatment of core PTSD symptoms. That distinction requires a clinician’s judgment and should not be turned into a self-directed medication change. If the patient already takes a medicine, the teams need to plan continuity and review safely.
Ask who will prescribe after return and whether the proposed treatment can be continued in the home jurisdiction. A discharge summary should include the rationale for changes and necessary monitoring. A residential end date is not a sufficient reason to interrupt a clinically indicated plan.
Address safety and ongoing circumstances
NIMH’s PTSD guidance notes that ongoing trauma needs attention alongside symptoms. Ask whether the home circumstances, housing, relationships, or other current threats affect treatment and discharge. Temporary distance abroad does not itself resolve those practical concerns.
Clarify how the program manages urgent psychiatric or medical needs and what would require hospital care. If there is immediate danger, use appropriate local emergency support rather than wait for a planned overseas stay. The admissions team should not substitute for an urgent clinical assessment.
Consent and communication should be practical. Ask how therapy expectations are explained, how the person can raise concerns, and what family involvement is proposed. The patient’s account and preferences should remain central, including when treatment involves sensitive memories or unfamiliar surroundings.
Measure both symptom change and functioning
The VA recommends ongoing assessment and shared decisions in co-occurring PTSD and substance use care. Ask how the program tracks each concern and discusses results with the patient. A single overall impression may miss progress in one area and a persistent problem in another.
Include daily-life goals such as participation, relationships, sleep, or responsibilities where relevant. Those goals should be defined individually. The team should also distinguish change inside a protected residence from the work needed to manage the situations the person will encounter at home.
Arrange a combined handover
Discuss what happens if a substance use episode occurs during trauma treatment. The response should follow an individualized reassessment of safety, support, and the treatment plan. Ask whether the same clinicians will remain involved, how sessions may be adjusted, and how a temporary transfer would be coordinated. A written explanation of these arrangements is more useful than an assurance that the program handles every complication internally.
Before discharge, identify the professionals who will continue PTSD treatment, substance use care, and prescribing. Ask for a shared account of the formulation, methods used, progress, remaining concerns, and next steps. If several services are involved, name the person responsible for connecting them.
Our aftercare guide supports that transition. Compare international programs by their ability to offer appropriate care for both disorders and preserve it across the move home. The strongest plan makes the relationship between treatments clear and keeps responsibility from falling into the gaps between services.